Robert J. Mauthe

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 461 citations

Pharmacy, Pharmaceutics, Toxicology +12

SFTG international collaborative study on in vitro micronucleus test

Marilyn J. Aardema, Ronald D. Snyder, Carol S. Spicer et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2006 · 91 citations

Pharmacy, Toxicology, Histology +7

MeIQx-DNA adduct formation in rodent and human tissues at low doses

Kenneth W. Turteltaub, Robert J. Mauthe, Karen H. Dingley et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 1997 · 84 citations

Pharmacy, Molecular Biology, Toxicology +10

Exposure of mammalian cell cultures to benzo[<i>a</i>] and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation

Robert J. Mauthe, Vanessa M. Cook, Stephanie L. Coffing et al. · Carcinogenesis · 1995 · 70 citations

Pharmacy, Molecular Biology, Toxicology +17

Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose

Robert J. Mauthe, Karen H. Dingley, Steven H. Leveson et al. · International Journal of Cancer · 1999 · 54 citations

Medicine, Oncology, Toxicology +9